This inventor holds 8 USPTO granted patents and 3 EPO patents. Top assignee: Chirogate International Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Inventor Jian-Bang Jheng: Innovating Pharmaceutical Solutions in Yangmei, TW
Introduction: Jian-Bang Jheng is a prominent inventor based in Yangmei, Taiwan, with a remarkable portfolio that includes seven patents. He is recognized for his significant contributions to the field of pharmaceuticals, particularly in the development of crystalline forms of Treprostinil. His innovative approach enhances the stability and efficiency of pharmaceutical formulations.
Latest Patents: Two of Jian-Bang Jheng's latest patents reflect his dedication to improving Treprostinil preparations. The first patent, titled "Treprostinil monohydrate crystals and methods for preparation thereof," presents novel crystalline forms of Treprostinil monohydrate and their preparation methods. The second patent, "Efficient crystallization process for preparing ultrapure Treprostinil and crystal prepared therefrom," introduces a stable crystalline Form I of anhydrous Treprostinil. This crystalline form is advantageous for its steady physicochemical properties, enabling safer storage, shipment, and handling in commercial applications.
Career Highlights: Jian-Bang Jheng is affiliated with Chirogate International Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has garnered attention for its potential to improve medication efficacy and patient safety.
Collaborations: Jian-Bang collaborates with notable peers in his field, including Shih-Yi Wei and Ming-Kun Hsu, contributing to a dynamic research environment that fosters innovation and practical advancements in pharmaceutical technologies.
Conclusion: With seven patents to his name, Jian-Bang Jheng stands out as an innovative force in the pharmaceutical industry. His commitment to developing efficient and safe formulations of Treprostinil showcases his dedication to improving healthcare solutions. As he continues to collaborate with talented professionals, the impact of his inventions will undoubtedly benefit the pharmaceutical landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile